Addressing Unmet Needs in Scalp Psoriasis: A Look at Current Management Strategies
Course Director, Jerry Bagel, MD, MS, discusses scalp psoriasis in this CME activity titled "Addressing Unmet Needs in Scalp Psoriasis: A Closer Look at Current Management Strategies and the Clinical Potential of New Therapeutic Options." For the full presentation, downloadable infographics, complete CME information, and to apply for credit, please visit us at http://www.peerview.com/DNF865. CME credit will be available until January 30, 2020.
Видео Addressing Unmet Needs in Scalp Psoriasis: A Look at Current Management Strategies канала PeerView CME
Видео Addressing Unmet Needs in Scalp Psoriasis: A Look at Current Management Strategies канала PeerView CME
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Drs. Chodos & Neel discuss #AlzheimersDisease at #IM2023 - https://bit.ly/41gVwsn
Non–Cystic Fibrosis Bronchiectasis: Leveraging Early Diagnosis and Emerging Therapies
PCSK9-Targeting Strategies to Achieve Lipid Goals & Reduce CV Risks in Hyperlipidemia
Severe Asthma: Directing New Treatment Approaches at the Airway Epithelium
Episode 5. State-of-the-Art Treatment: Catching Up With Current Guidelines
Strategies for Improving Outcomes in Hypertrophic Cardiomyopathy
Episode 4: How Can We Talk About VTE to Our Patients?
Updating Our Cardio-Oncology Skills in the Cancer Immunotherapy Era: Management of Cardiac irAEs
Applying Evidence to Practice in Postpartum Depression
Watch Drs. Bar-Or & Oh discuss #MultipleSclerosis updates from #CMSC - https://bit.ly/2024MSY
FcRn Modulation in Myasthenia Gravis: Applying the Evidence, Tools, and Patient Perspectives
Overcoming Challenges in the Management of Moderate to Severe AD
Leveraging the Power of Anti-CD20 mAbs in Patient-Centric Multiple Sclerosis Care
Facilitating Cognitive Assessment in Primary Care for Timely Detection of Alzheimer’s Disease
New Developments in Allergic and Inflammatory Diseases
Individualizing Treatment With GLP-1 RAs to Reduce Cardiovascular Risks in Patients With T2DM
Targeted Biologic Therapy for Pediatric and Adult Patients With Moderate to Severe AD
Improving the Management of CRS/NP: Selecting the Right Patients for Targeted Treatment
HBV Is Primary! Your Role in the "Call to Action" to Eliminate Viral Hepatitis By 2030
Clinical Utility of Mucus Plugging and Airway Hyperresponsiveness
Episode 6. Is That Realistic? What We’ve Learned About Anticoagulation Therapy Real-World Studies